Camber launches Micardis generic

Camber launches Micardis generic

PISCATAWAY, N.J. — Camber Pharmaceuticals on Wednesday announced the introduction of its generic of Boehringer Ingelheim’s Micardis (telmisartan) tablets. The drug is indicated to treat hypertension.

ChemSpider 2D Image | Telmisartan | C33H30N4O2

Camber’s generic will be available in 20-, 40-, and 80-mg dosage strengths and packaged in 3×10 blister cards.

About Camber Pharmaceuticals 

Through its parent company, Hetero Drugs of Hyderabad India, Camber is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.


June 23, 2017 / Pharma News